Dr. Daniel Michael Wlodarczyk, MD

Dr. Wlodarczyk practices at Maria X Martinez Health Resource Center in San Francisco, California.

Dr. Wlodarczyk's NPI, 1700993524, was assigned on August 25, 2006. Dr. Wlodarczyk holds California license G42994.

Dr. Wlodarczyk's primary practice is Maria X Martinez Health Resource Center, at 50 Ivy St, San Francisco, CA 94102 in San Francisco County. The practice phone is (628) 217-5800.

Dr. Wlodarczyk's primary practice is Maria X Martinez Health Resource Center in San Francisco, California. The medical group on file is San Francisco Public Health Laboratory. Dmand AI also links Dr. Wlodarczyk to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wlodarczyk practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Wlodarczyk's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Wlodarczyk is licensed in California.

CMS data shows 125 Medicare services from Dr. Wlodarczyk across 3 procedure codes in 2017, for 11 Medicare patients. Medicare paid $7,305 for them. Every service was in an office.

CMS counts 11 Medicare patients who saw Dr. Wlodarczyk in 2024. The largest group is 85 and over, with 0 patients. 100% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wlodarczyk's median patient age at 62, with 29% women.

In 2024, Dr. Wlodarczyk wrote 119 Medicare Part D claims for 32 patients. 66% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $6,575 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wlodarczyk for performance year 2024, reported as part of a group. Dr. Wlodarczyk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Wlodarczyk in 2021. The most frequent topics are Cause of Death, HIV Infections and San Francisco. Dr. Wlodarczyk's most frequent co-authors are Susan Pamela Buchbinder, MD, Katerina A. Christopoulos, MD, MPH and David Wesley Dowdy, MD, PhD.

CMS Open Payments shows 5 general payments to Dr. Wlodarczyk from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 75% of the total. Gilead Sciences, Inc. paid the most, $89.